Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mannweiler

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Clinical Chemistry|March 15, 2008
Development of a multiplexed urine assay for prostate cancer diagnosisTatiana Vener, Carlo Derecho, Jonathan Baden, et al.
Minerva Urology and Nephrology|January 19, 2026
MRI prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRI-targeted biopsyHanna Zurl, Stefan Embacher, Helmut Schöllnast, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Genome Medicine|April 9, 2013
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencingEllen Heitzer, Peter Ulz, Jelena Belic, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Frontiers in Surgery|October 24, 2022
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patientsJohannes Mischinger, Helmut Schöllnast, Hanna Zurl, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Clinical Chemistry|March 15, 2008
Development of a multiplexed urine assay for prostate cancer diagnosisTatiana Vener, Carlo Derecho, Jonathan Baden, et al.
Minerva Urology and Nephrology|January 19, 2026
MRI prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRI-targeted biopsyHanna Zurl, Stefan Embacher, Helmut Schöllnast, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Genome Medicine|April 9, 2013
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencingEllen Heitzer, Peter Ulz, Jelena Belic, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Frontiers in Surgery|October 24, 2022
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patientsJohannes Mischinger, Helmut Schöllnast, Hanna Zurl, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Pageof 5